Teresa L. Kline
CIK: 0001712647
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Kline Teresa L.
Kline Teresa L. (SEC CIK 0001712647) files insider reports with the SEC as Director of ACCENDRA HEALTH INC/VA/ (ACH) and Director of AMEDISYS INC (AMED).
Signal8 holds 4 ownership filings by Kline Teresa L., all Form 4s, filed between May 6, 2025 and May 18, 2026. Those filings report 4 transactions, from May 3, 2025 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kline Teresa L.'s filings is in GLEN ALLEN, VA.
Recent filings by Kline Teresa L.
Other insiders filing for ACCENDRA HEALTH INC/VA/ (ACH)
- Gardner-Smith Kenneth, President & CEO
- Leon Jonathan A, EVP & CFO
- Galloway Heath H, EVP,General Counsel & CorpSecy
- Pesicka Edward A, President & CEO
- Bernocchi Perry A, EVP, Chief Operating Officer
- Klemash Stephen W, Director